Bibliografia Alkazym plus

1) Biotechnol Res Int. 2012. Properties and therapeutic application of bromelain: a review. Rajendra Pavan, Sapna Jain, Shraddha, Ajay Kumar.

 

2)Pereira IC, Sátiro Vieira EE, de Oliveira Torres LR, Carneiro da Silva FC, de Castro E Sousa JM, Torres-Leal FL. Bromelain supplementation and inflammatory markers: A systematic review of clinical trials. Clin Nutr ESPEN. 2023 Jun;55:116-127.

 

3) Rathnavelu V, Alitheen NB, Sohila S, Kanagesan S, RameshR. Potential role of bromelain in clinical and therapeuticapplications. Biomed Rep. 2016;5: 283-288. doi:10.3892/br.2016.720.

 

4) Ley CM, Tsiami A, Ni Q, Robinson N. A review of the use ofbromelain in cardiovascular diseases. Zhong Xi Yi Jie He Xue Bao. 2011;9: 702-710. doi:10.3736/jcim20110702.

 

5) Pandey S, Cabot PJ, Shaw PN, Hewavitharana AK. Anti-inflammatory and immunomodulatory properties of Caricapapaya. Journal of Immunotoxicology. 2016; 13(4): 590-602

 

6) Duru MK, Amadi BA, Amadi CT, Lele KC, Anudike JC, Chima-Ezika OR, Osuocha K. 2012. Toxic effects of Carica papaya bark on body weight, hematology, and some biochemical parameters. Biokemistri 24:67–71.

 

7) Ezekiel A, Florence M. 2012. Papain, a plant enzyme of biological importance: A review. Am J Biochem Biotechnol. 8:99–104.

 

8) Rice Compounds with Impact on Diabetes Control. Foods. 2021 Aug 25;10(9):1992.

 

9) Biological and Pharmacological Effects of Gamma-oryzanol: An Updated Review of the Molecular Mechanisms. Curr Pharm Des. 2021;27(19):2299-2316.

 

10) Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Giappone. Kozuka C, Sunagawa S, Ueda R, Higa M, Ohshiro Y, Tanaka H, et al. A novel insulinotropic mechanism of whole grain- derived γ-oryzanol via the suppression of local dopamine D2 receptor signaling in mouse islet. Br J Pharmacol 2015, Jul 3 [Epub]

 

11) Tamagawa M,et al. Carcinogenity study of gamma-oryzanol in B6C3F1 mice. Food Chem Toxicol , 30, pp 49-56, 1992.

 

12)  Tamagawa M,et al. Carcinogenity study of gamma-oryzanol in F344 mice. Food Chem Toxicol , 30, pp 41-48, 1992.

 

13) Xu Z, Hua N, God ber JS. Antioxidant Activity of Tocopheroles, Tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2‘-Azobis(2-methylpropionamide)dihydrochloride. J Agri food Chem May-Jun, 49 (4), pp 2077-81, 2001.

 

14) Added gamma-oryzanol boosted anti-inflammatory effects of canola oil in adult subjects with type 2 diabetes: a randomized controlled clinical trial. Eur J Nutr. 2024 Mar;63(2):425-433.

 

15) Daily consumption of gamma-oryzanol-fortified canola oil, compared with unfortified canola and sunflower oils, resulted in a better improvement of certain cardiometabolic biomarkers of adult subjects with type 2 diabetes: a randomized controlled clinical trial. Eur J Med Res. 2023 Oct 10;28(1):416.

 

16) Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?; Fabiane Valentini Francisqueti-Ferron et Al; Mol Cell Endocrinol. 2020 Nov 28;520:111095.